9Renal, Hepatic and Electrolyte Causes

FThe kidney-cochlea connection

The inner ear and the kidney are unlikely twins. Both depend on epithelia that pump ions to maintain exquisitely controlled fluid compartments — the stria vascularis in the cochlea, the nephron in the kidney — and they share transport proteins and developmental genes. Several inherited syndromes, most famously Alport syndrome, hit both organs together, which is the clearest demonstration of how closely their fates are linked.

That shared biology explains why systemic disturbances of fluid and chemistry can echo in the ear. When the kidneys fail, when the liver decompensates, or when electrolytes and acid-base balance drift, the finely tuned environment the cochlea needs is disturbed — and tinnitus can be the audible result [2013].

TChronic kidney disease and hearing

Chronic kidney disease (CKD) is consistently associated with hearing loss and tinnitus. Large cohort and registry analyses report a meaningfully increased risk of hearing impairment in people with reduced kidney function compared with the general population, with the effect more pronounced at higher frequencies and in more advanced disease [2026].

Several mechanisms operate at once. Uraemic toxins are directly injurious to the cochlea; shared microvascular disease from coexisting hypertension and diabetes compromises cochlear perfusion; electrolyte and osmotic shifts disturb endolymph homeostasis; and patients with CKD are frequently exposed to ototoxic drugs that the failing kidney cannot clear efficiently. A systematic review of hearing and balance in CKD confirms that both auditory and vestibular function are affected across the disease spectrum [2024].

CThe dialysis-associated pattern

Patients on dialysis form a recognisable subgroup. Their tinnitus and hearing change can fluctuate around the dialysis session, reflecting the rapid osmotic and electrolyte shifts that haemodialysis produces — the same fluid movements that can transiently change cochlear and endolymphatic pressures. Symptoms reported peri-dialysis are a clue to this mechanism rather than to a fixed structural lesion.

Two further factors compound the picture. First, drug accumulation: a failing kidney clears ototoxic agents — aminoglycosides, certain loop diuretics, vancomycin — poorly, so standard doses can reach inner-ear-toxic levels. Loop diuretics in particular act directly on the stria vascularis and can potentiate aminoglycoside ototoxicity. Second, the cumulative burden of years of uraemia and microvascular disease. The practical message is to review the drug chart relentlessly, dose-adjust for renal function, and consider the dialysis schedule when symptoms fluctuate [2024].

THepatic disease and electrolyte disturbance

Liver disease contributes less directly but is not silent. Advanced hepatic dysfunction brings impaired drug metabolism (raising the risk from ototoxic medications), coagulopathy and altered vascular tone, anaemia, and in some cases the systemic effects of viral hepatitis or its antiviral treatment — all of which can act on the auditory system or amplify tinnitus distress through fatigue and poor sleep.

Electrolyte and acid-base disturbances form the final thread. Sodium, potassium, calcium and magnesium are central to the ionic currents on which hair-cell transduction and neural firing depend, and acid-base shifts alter neuronal excitability. Rapid correction of these derangements — as happens during dialysis or aggressive medical treatment — can itself provoke transient auditory symptoms. Magnesium has attracted particular interest as both a potential protective factor against ototoxicity and a modulator of cochlear excitability.

CA practical work-up

When tinnitus appears in a patient with known or suspected renal or hepatic disease, the work-up is targeted rather than exhaustive. Check renal function and electrolytes (including calcium and magnesium), and review the dialysis schedule if relevant. Scrutinise the medication list for ototoxic agents and confirm each is dose-adjusted for renal and hepatic function.

Audiometry establishes a baseline and often shows the high-frequency pattern typical of systemic injury; serial testing helps separate fluctuating, potentially reversible change from fixed loss. The therapeutic levers are mostly systemic: optimise the underlying disease, minimise and adjust ototoxic exposure, time decisions around dialysis, and correct electrolyte derangements at a measured pace. Where damage is fixed, the management converges on the rest of tinnitus care — sound therapy, hearing-aid amplification and attention to mood and sleep [2014].